Oropharynx
5 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Phase II Trial of Neoadjuvant Chemotherapy (NAC) Alone or in Combination With Immunotherapy Vaccine PRGN-2009 in Subjects With Newly Diagnosed HPV-Associated Oropharyngeal (Head and Neck) Cancer (NCT06223568) | National Cancer Institute (NCI) | 2024-06-10 |
| PuraBond® and Pain Following Resection of Oral or Oropharyngeal Mucosal Lesions (NCT05773781) | University of Liverpool | 2023-10-16 |
| Window of Opportunity Trial of Durvalumab (MEDI4736) or Durvalumab/Tremelimumab as Neoadjuvant Chemotherapy to Identify Immune Dynamics in Surgically Resectable Head and Neck Cancer Patients. (NCT03737968) | Yonsei University | 2019-01-02 |
| Do Traditional or Flavored Tongue Depressors Make for Easier Posterior Oropharynx Exams in Pediatric Patients (NCT03095183) | Brooke Army Medical Center | 2016-08-24 |
| Ex Vivo Multimodal Imaging of Upper Aerodigestive Epithelium (NCT01321892) | Icahn School of Medicine at Mount Sinai | 2009-06-01 |
Track Oropharynx automatically
Every clearance here is in the API, with alerts when new ones post.